EUDA Health Targets Longevity Market with Upgraded Helixé 2.0 Supplement

SINGAPORE – December 29, 2025 – EUDA Health Holdings has announced the upcoming January 2026 launch of EUDA Helixé 2.0, a significant upgrade to its premium longevity supplement. The move signals the Singapore-based company's intensified focus on the rapidly expanding global wellness and anti-aging sector, a market projected to surpass $327 billion by 2030. The new version introduces a more potent formula, advanced nutrient delivery technology, and a crucial Halal certification aimed at unlocking new international markets.

This launch comes as EUDA Health navigates a challenging financial landscape while making aggressive strategic plays in non-invasive healthcare. The company is betting that science-backed consumer products like Helixé 2.0 will form a profitable pillar in its broader mission to address the healthcare needs of Asia's rapidly aging population.

The Science of a Next-Generation Supplement

At the core of the EUDA Helixé 2.0 upgrade is a re-engineered formulation and delivery system designed for superior efficacy. The company has increased the concentration of its key ingredient, New Zealand-sourced deer placenta powder, by 20%, raising the dosage from 100 mg to 120 mg per capsule. Deer placenta extract is rich in growth factors, proteins, and amino acids, which proponents claim can support cellular maintenance and skin integrity. While some users report benefits like improved skin radiance, independent scientific analysis cautions against marketing claims of "live stem cells." Research into similar products has found no evidence of viable stem cells, and regulators classify these products as food supplements with no approved therapeutic claims.

In a notable formulation change, EUDA has replaced the amino acid L-glutathione with D-alpha-tocopherol, a natural form of Vitamin E. The company states this substitution is intended to improve antioxidant stability, enhance cellular protection from free radical damage, and bolster skin health—aligning the product more closely with long-term anti-aging objectives. Vitamin E is a well-established antioxidant widely recognized for its benefits in dermatological health.

The most significant technological leap is the adoption of a new delivery platform. The previous enteric coating, designed to protect ingredients from stomach acid, has been replaced with nano emulsification. This cutting-edge technology breaks down oil-based ingredients into nano-sized droplets, dramatically increasing their surface area and solubility. According to research in nutraceuticals, this process can significantly improve the bioavailability and absorption speed of hydrophobic compounds like Vitamin E, ensuring more efficient nutrient delivery. This advanced system, combined with freeze-drying for powder ingredients and nitrogen encapsulation to prevent oxidation, allows for a smaller, easier-to-swallow capsule while aiming to enhance functional efficacy and shelf life.

A Strategic Push into Global Markets

The launch of EUDA Helixé 2.0 is as much a strategic business maneuver as it is a product enhancement. The supplement has secured New Zealand Halal certification, a pivotal achievement that opens the door to vast and previously untapped consumer markets. With approximately one in four global consumers adhering to Halal dietary standards, this certification is a critical enabler for EUDA’s planned expansion into Muslim-majority countries across Southeast Asia and the Middle East, including Indonesia, Malaysia, Saudi Arabia, and the United Arab Emirates.

Certification from a New Zealand body is particularly valuable, as the country's Halal regulatory framework is highly respected and recognized by authorities in major Islamic markets. This provides EUDA with a significant advantage in gaining consumer trust and navigating complex international trade regulations. The move positions the company to compete directly in the global Halal economy, a market valued in the trillions of dollars.

"This marks an important milestone in EUDA’s product evolution," commented Mr. Alfred Lim, CEO of EUDA, in the official announcement. "With EUDA Helixé 2.0, we are strengthening our core formulation, upgrading delivery technology and expanding global market accessibility through Halal certification. These enhancements reflect our commitment to science-backed innovation and position EUDA Helixé as a premium longevity supplement aligned with EUDA’s broader strategy to scale high-quality wellness solutions globally.”

Navigating a High-Stakes Wellness Industry

EUDA Health's ambitious product launch occurs within the context of a fiercely competitive market and a mixed financial picture for the company. The global longevity and anti-aging market is booming, with some forecasts predicting it will reach nearly $58.5 billion by 2035, growing at an impressive CAGR of 11.9%. The Asia-Pacific region is the fastest-growing segment, driven by rising disposable incomes and a cultural emphasis on proactive health.

While EUDA reported impressive year-over-year revenue growth of 83.7%, primarily from property management and new wellness products, its path to profitability remains a concern for investors. The company's stock (NASDAQ: EUDA) has declined approximately 47% over the past year. An amended annual report for fiscal year 2024 included an auditor's note expressing "substantial doubt" about the company's ability to continue as a "going concern" due to accumulated deficits and ongoing losses. The company has relied on equity offerings to fund its operations, raising concerns about potential shareholder dilution.

Despite these challenges, EUDA is aggressively pursuing a multi-pronged growth strategy. The company is expanding into regenerative medicine and recently announced the launch of a nationwide stem cell extraction and storage platform in China. The EUDA Helixé 2.0 launch is a key part of this broader strategy, aiming to establish a strong revenue stream from consumer health products while the company builds out its clinical and technology platforms. This launch positions EUDA Helixé 2.0 not just as a product, but as a key component in the company's ambitious strategy to redefine health and wellness for an aging Asia.